Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
dc.contributor.author | Voß, Daniel | |
dc.contributor.author | Pfefferle, Susanne | |
dc.contributor.author | Drosten, Christian | |
dc.contributor.author | Stevermann, Lea | |
dc.contributor.author | Traggiai, Elisabetta | |
dc.contributor.author | Lanzavecchia, Antonio | |
dc.contributor.author | Becker, Stephan | |
dc.date.accessioned | 2018-05-07T13:23:26Z | |
dc.date.available | 2018-05-07T13:23:26Z | |
dc.date.created | 2009-11-25 | |
dc.date.issued | 2009-06-18 | none |
dc.identifier.other | http://edoc.rki.de/oa/articles/reGJuFs1aLTQ/PDF/28c8lvWlPkKV2.pdf | |
dc.identifier.uri | http://edoc.rki.de/176904/481 | |
dc.description.abstract | The glycosylated membrane protein M of the severe acute respiratory syndrome associated coronavirus (SARS-CoV) is the main structural component of the virion and mediates assembly and budding of viral particles. The membrane topology of SARS-CoV M and the functional significance of its N-glycosylation are not completely understood as is its interaction with the surface glycoprotein S. Using biochemical and immunofluorescence analyses we found that M consists of a short glycosylated N-terminal ectodomain, three transmembrane segments and a long, immunogenic C-terminal endodomain. Although the N-glycosylation site of M seems to be highly conserved between group 1 and 3 coronaviruses, studies using a recombinant SARS-CoV expressing a glycosylation-deficient M revealed that N-glycosylation of M neither influence the shape of the virions nor their infectivity in cell culture. Further functional analysis of truncated M proteins showed that the N-terminal 134 amino acids comprising the three transmembrane domains are sufficient to mediate accumulation of M in the Golgi complex and to enforce recruitment of the viral spike protein S to the sites of virus assembly and budding in the ERGIC. | eng |
dc.language.iso | eng | |
dc.publisher | Robert Koch-Institut; Robert Koch-Institut, Infektionskrankheiten / Erreger | |
dc.subject | Virus Replication | eng |
dc.subject | Cell Line | eng |
dc.subject | Humans | eng |
dc.subject | Animals | eng |
dc.subject | Amino Acid Substitution | eng |
dc.subject | Cercopithecus aethiops | eng |
dc.subject | Glycosylation | eng |
dc.subject | Golgi Apparatus/virology | eng |
dc.subject | Membrane Glycoproteins/metabolism | eng |
dc.subject | Mutagenesis | eng |
dc.subject | Site-Directed | eng |
dc.subject | SARS Virus/chemistry | eng |
dc.subject | SARS Virus/physiology | eng |
dc.subject | Sequence Deletion | eng |
dc.subject | Viral Envelope Proteins/metabolism | eng |
dc.subject | Viral Matrix Proteins/genetics | eng |
dc.subject | Viral Matrix Proteins/metabolism | eng |
dc.subject | Virus Internalization | eng |
dc.subject.ddc | 610 Medizin | |
dc.title | Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein | |
dc.type | periodicalPart | |
dc.identifier.urn | urn:nbn:de:0257-1002903 | |
dc.identifier.doi | 10.1186/1743-422X-6-79 | |
dc.identifier.doi | http://dx.doi.org/10.25646/406 | |
local.edoc.container-title | Virology Journal | |
local.edoc.fp-subtype | Artikel | |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-url | http://www.virologyj.com/content/6/1/79 | |
local.edoc.container-publisher-name | BioMed Central | |
local.edoc.container-volume | 6 | |
local.edoc.container-year | 2009 |